NCT05414370View on ClinicalTrials.gov

Hyperoxia Induced Pulmonary Inflammation and Organ Injury: a Human in Vivo Model

NARecruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

December 2, 2022

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Oxygen ToxicityPulmonary InjuryAcute Lung Injury
Interventions
DRUG

Liquid oxygen

Liquid medical oxygen will be administered for 6 hours using high-flow nasal cannula delivery system with an Fi02 of 100% and flow rate of 60 litres per minute.

DRUG

medical air

Synthetic medical air will be administered for 6 hours using high-flow nasal cannula delivery system with a flow rate of 60 litres per minute.

Trial Locations (1)

Unknown

RECRUITING

Belfast Health and Social Care Trus, Belfast

All Listed Sponsors
lead

Belfast Health and Social Care Trust

OTHER